In cases of secondary resistance, the SMO mutations that were isolated were not present in the primary tumors that had originally responded to treatment, and distinct recurrent nodules of BCC demonstrated unique SMO mutations, suggesting a heterogeneous and dynamic mechanism of resistance that can rapidly arise in recurrent tumor tissue79. The gene discussed is SMO; the disease is neoplasm.